GlaxoSmithKline’s Core Revolving Credit Facilities Refinancing

Sidley Austin LLP advised GlaxoSmithKline plc on the deal. GlaxoSmithKline plc (GSK) announced the refinancing of its core revolving credit facilities consisting of US$2.5 billion of…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now